Secure Supply Chain Pilot Program Participants
Thirteen firms will test FDA’s effort to expedite imports.
You may also be interested in...
One of US FDA’s most important publications ever, the Orange Book celebrates 40 years as the definitive guide to approved drug products and therapeutic equivalents. Even as the color has receded from the book itself, orange still generates appreciation from regulators and outside attorneys.
CDC officials designing distribution plans worry some eligible for vaccination may wait for a better product to emerge.
With some studies about to finish and others on clinical hold, the coronavirus vaccine field approaches an inflection point as the US FDA prepares for its first advisory committee on the topic. Our charts and graphics offer a quick look at what stands where.